When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OTSKF - Teva's Ajovy successful in two migraine studies in Japan
Otsuka Holdings Co. Ltd.
Teva Pharmaceutical Industries (NYSE:TEVA) announces positive results from two Phase 2/3 clinical trials in Japan evaluating Ajovy (fremanezumab) in patients with chronic and episodic migraine.
More news on: Teva Pharmaceutical Industries Limited, Otsuka Holdings Co., Ltd., Otsuka Holdings Co., Ltd., Healthcare stocks news,